skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Special Considerations Regarding the Use of Antiretroviral Drugs by HIV-Infected Pregnant Women and Their Infants

Overview
Pharmacokinetic Changes
Teratogenicity
Combination Antiretroviral Drug Regimens and Pregnancy Outcome
Nevirapine and Hepatic/Rash Toxicity
Nucleoside Reverse Transcriptase Inhibitor Drugs and Mitochondrial Toxicity
Protease Inhibitor Therapy and Hyperglycemia